Salvadori Daniel Gesua Sive's Form 4 filing
Abbott Laboratories (ABT) · filed Dec 15, 2021
- Accession no.
- 0001415889-21-005967
- Filed
- Dec 15, 2021
- Trade date
- Dec 13, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.90M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salvadori Daniel Gesua SiveCIK 0001620564 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common shares without par value | SSaleDisposed | −3,499 | $135.00 | −$472,365 | 103,931 | Direct | |
| Dec 13, 2021 | Common shares without par value | MOption exerciseAcquired | +23,771 | $38.40 | +$912,806.4 | 127,702 | Direct | |
| Dec 13, 2021 | Common shares without par value | MOption exerciseAcquired | +31,229 | $44.40 | +$1,386,567.6 | 158,931 | Direct | |
| Dec 13, 2021 | Common shares without par value | SSaleDisposed | −55,000 | $135.00 | −$7,425,000 | 103,931 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common Shares | MOption exerciseDisposed | −23,771 | $0.00 | $0 | 47,542 | Direct | |
| Dec 13, 2021 | Common Shares | MOption exerciseDisposed | −31,229 | $0.00 | $0 | 60,803 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).